DE69935313D1 - Nachweisverfahren für peptide - Google Patents

Nachweisverfahren für peptide

Info

Publication number
DE69935313D1
DE69935313D1 DE69935313T DE69935313T DE69935313D1 DE 69935313 D1 DE69935313 D1 DE 69935313D1 DE 69935313 T DE69935313 T DE 69935313T DE 69935313 T DE69935313 T DE 69935313T DE 69935313 D1 DE69935313 D1 DE 69935313D1
Authority
DE
Germany
Prior art keywords
proof
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69935313T
Other languages
English (en)
Other versions
DE69935313T2 (de
Inventor
Paul M Watt
Ursula R Kees
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phylogica Ltd
Original Assignee
Phylogica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phylogica Ltd filed Critical Phylogica Ltd
Publication of DE69935313D1 publication Critical patent/DE69935313D1/de
Application granted granted Critical
Publication of DE69935313T2 publication Critical patent/DE69935313T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69935313T 1998-01-09 1999-01-08 Nachweisverfahren für peptide Expired - Fee Related DE69935313T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7098998P 1998-01-09 1998-01-09
US70989P 1998-01-09
PCT/AU1999/000018 WO1999035282A1 (en) 1998-01-09 1999-01-08 Peptide detection method

Publications (2)

Publication Number Publication Date
DE69935313D1 true DE69935313D1 (de) 2007-04-12
DE69935313T2 DE69935313T2 (de) 2007-11-15

Family

ID=22098592

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69935313T Expired - Fee Related DE69935313T2 (de) 1998-01-09 1999-01-08 Nachweisverfahren für peptide

Country Status (6)

Country Link
US (1) US6610495B1 (de)
EP (1) EP1053347B1 (de)
AU (1) AU735887B2 (de)
CA (1) CA2317816C (de)
DE (1) DE69935313T2 (de)
WO (1) WO1999035282A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803765B2 (en) 1999-05-05 2010-09-28 Phylogica Limited Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom
DK2230303T3 (da) * 1999-05-05 2013-04-15 Phylogica Ltd Isolering af biologiske modulatorer fra biodiverse genfragment-biblioteker
US7270969B2 (en) 1999-05-05 2007-09-18 Phylogica Limited Methods of constructing and screening diverse expression libraries
DE60034947T2 (de) * 1999-06-30 2008-01-24 Evotec Ag Virusähnliche partikel, vorbereitung und verwendung in screening und funktionelle genomanwendung
GB9924858D0 (en) * 1999-10-20 1999-12-22 Medical Res Council Modulation of angiogensis
US7018801B2 (en) * 2000-02-11 2006-03-28 Board Of Regents, The University Of Texas System Selection of peptides with antibody-like properties
WO2001066787A1 (en) * 2000-03-08 2001-09-13 Tvw Telethon Institute For Child Health Research Improved reverse n-hybrid screening method
AT500023B1 (de) * 2001-09-27 2007-09-15 Bmt Medizinische Forschung Und Funktioneller screen für transskriptionsfaktoren
US7056665B2 (en) * 2002-01-16 2006-06-06 Panomics, Inc. Screening methods involving the detection of short-lived proteins
US20030134287A1 (en) * 2002-01-16 2003-07-17 Xianqiang Li Method for isolating and characterizing short-lived proteins
WO2004106543A1 (en) * 2003-05-30 2004-12-09 Phylogica Limited An improved genetic screen for interaction interface mapping
US20080020409A1 (en) * 2004-03-03 2008-01-24 Michael Pawlak Analytical Platform and Method for Generating Protein Expression Profiles of Cell Populations
CA2638912A1 (en) 2006-02-20 2007-08-30 Phylogica Limited Method of constructing and screening libraries of peptide structures
CA2663545A1 (en) 2006-09-19 2008-03-27 Phylogica Limited Neuroprotective peptide inhibitors of ap-1 signaling and uses thereof
US8822409B2 (en) 2007-06-20 2014-09-02 Phylogica Limited Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ARDS) and clinical disorders associated with therewith
JP7080878B2 (ja) 2016-05-27 2022-06-06 シンセックス， インコーポレイテッド タンパク質界面
WO2019104244A1 (en) 2017-11-22 2019-05-31 Synthex, Inc. Peptides for inhibiting rad51

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322801A (en) 1990-04-19 1994-06-21 The General Hospital Corporation Protein partner screening assays and uses thereof
DE9215761U1 (de) 1992-11-20 1993-02-11 Malü, Christoph, 24143 Kiel Plombe zum Sichern des Verschlusses eines Sterilisationsbehälters
GB9303988D0 (en) * 1993-02-26 1993-04-14 Health Lab Service Board Bi-functional expression systems
US5470953A (en) 1993-12-23 1995-11-28 Icos Corporation Human β2 integrin α subunit
WO1995020652A1 (de) 1994-01-28 1995-08-03 Medigene Gmbh Verfahren zur bestimmung der aktivität eines regulatorischen faktors sowie verwendung dieses verfahrens
US5525490A (en) 1994-03-29 1996-06-11 Onyx Pharmaceuticals, Inc. Reverse two-hybrid method
US5989808A (en) 1994-06-14 1999-11-23 American Cyanamid Company Identification of compounds affecting specific interaction of peptide binding pairs
US5695941A (en) * 1994-06-22 1997-12-09 The General Hospital Corporation Interaction trap systems for analysis of protein networks
US5582997A (en) * 1994-08-24 1996-12-10 Torrey Pines Institute For Molecular Studies Lysine/leucine polypeptides, mixture sets and libraries thereof
NZ306767A (en) * 1995-04-11 2000-03-27 Univ Johns Hopkins Method of identifying molecular interactions employing counterselection and at least two hybrid molecules or two hybrid systems
US5838299A (en) 1995-05-03 1998-11-17 Apple Computer, Inc. RGB/YUV video convolution system
US5654150A (en) * 1995-06-07 1997-08-05 President And Fellows Of Harvard College Method of expression cloning
US5846722A (en) * 1996-10-16 1998-12-08 Terrapin Technologies, Inc. System to detect small molecule/peptide interaction

Also Published As

Publication number Publication date
EP1053347A4 (de) 2003-08-27
AU735887B2 (en) 2001-07-19
CA2317816A1 (en) 1999-07-15
CA2317816C (en) 2009-02-17
AU2258799A (en) 1999-07-26
WO1999035282A1 (en) 1999-07-15
EP1053347B1 (de) 2007-02-28
EP1053347A1 (de) 2000-11-22
US6610495B1 (en) 2003-08-26
DE69935313T2 (de) 2007-11-15

Similar Documents

Publication Publication Date Title
DE69935313D1 (de) Nachweisverfahren für peptide
NO982097D0 (no) Peptider
NO982098D0 (no) Peptider
IS4664A (is) Ný peptíð-ópíóíð
DE69825763D1 (de) Versigelungssystem für trokar
DE69832291D1 (de) Abdichtungssystem für trokar
ATE317854T1 (de) Hepatitis c inhibitor peptide
NO20002324L (no) Innlagt bropakning
EP1115738A4 (de) Synthese zyklischer peptide
NO985680L (no) Peptidderivater
DE69617396T2 (de) T-Zellen beeinflussende Peptide
NO983849L (no) Peptidderivater
DK1124797T3 (da) N-Arylsulfonyl-aminosyre-omega-amider
DE69903553D1 (de) Verkapselung wasserlöslicher peptide
NO20012232D0 (no) Enzymatisk amidering av peptider
BR9606756A (pt) Peptídeo
DE69720266D1 (de) Vielfältig verzweigte peptidkonstruktionen
NO981052D0 (no) Peptidderivater
FI973371A0 (fi) Nya isolerade peptider
NO981051D0 (no) Peptidderivater
DE69633457D1 (de) Antineoplastische peptide
FI950211A (fi) Huokosia muodostavia peptidejä Geolycosa riograndesta
DE69506390T2 (de) Peptide für die inhibition der pepsinfreisetzung
SE9802536D0 (sv) Novel peptides
ATE277079T1 (de) Ice inhibierende peptide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee